Two-thirds of patients quit. Yours don’t have to.
Advisory & Keynote Speaking
Nearly two-thirds of people who start a GLP-1 for weight loss stop within a year. The medicine works. The system around it doesn’t. I help organizations close that last mile - on stage, in the boardroom, and in the build.
As seen on
Meet Dr. Ashley White
I'm a practicing obesity medicine physician (MD, MPH), the founder of The Shift Clinic, and the author of Monetizing Obesity Medicine: A Doctor's Framework for Patient Success at Scale (J. Ross Publishing, November 2026). I write The Clinical Last Mile, the newsletter for the people building what comes next in metabolic care. I write from two seats: the exam room and the operating system behind scaled care. Whether you book a keynote or a sprint, you get the same thing: clinical credibility that survives contact with your CFO.
Built for the people who own the problem
Advisory and speaking for the organizations deciding what GLP-1 era care actually looks like:
Digital health startups and scale-ups
Provincial health authorities
Private insurers
Self-insured employers
Consulting firms
Healthcare technology vendors
Investors
Healthcare advisory & keynote speaking services
Coverage Is a Clinical Intervention: Payer and Employer Strategy for the GLP-1 Era
Prior auth forms and benefit grids decide whether a patient stays in treatment as surely as any prescription does. Built for insurers, self-insured employers, and health authorities, this session reframes coverage design as a retention lever: who stops treatment and why, where plan design quietly pushes them out, and what it costs when they go. Available as a keynote or as a working advisory engagement, with pre-event alignment and post-event materials. Either way, you leave with a retention audit of your current plan design: where coverage is quietly pushing patients out, and the first moves to fix it.
The Last Mile Problem: Why Most GLP-1 Patients Quit Within a Year, and Who Gets Paid to Fix It
The industry solved the supply chain. It never built the system of care. So generational medications are being lost to system failures, and everyone in the room is paying for it, in churn, in spend, or in outcomes. This keynote puts the discontinuation crisis on the table as what it is: the biggest commercial opening in the category. Operators hear a cost problem. Payers hear a liability. Investors hear a market gap. Clinicians have déjà vu. Your audience leaves with a clear map of why patients leave, where the money leaks, and what the organizations that fix it early will own.
45-60 minutes, tailored pre-event strategy call, post-event summary brief for your team.
The Canopy Advisory Sprint
A working session, not a talk. Your team scores its own program against the Canopy Framework from Monetizing Obesity Medicine: seven components (Cost, Coverage, Care, Curriculum, Coach, Community, Connection), rated 0 to 3 on a simple maturity scale, using your own numbers. You leave with your Canopy profile, a ranked build order, the three to five KPIs worth tracking first, and a first-30-day move. It is the fastest way to see where your program is leaking, and it sets up everything that comes after.
Half-day, in person or virtual. Executive teams, clinical leadership, product and operations.
-
J. Ross Publishing, November 10, 2026.
Preorder: Amazon · Bookshop.org · Barnes & Noble · Amazon.ca · Indigo · Amazon UK · Waterstones
Hear more from Dr. White
“More than just novel obesity treatments” episode of the Canadian Medical Association Journal Podcast with Dr. Blair Bigham and Dr. Mojola Omole.
Phase to Phase: Beyond Calories: The Science of Weight Loss with Dr. Ashley White | Phase to Phase | S1 E2
This Time of the Month Podcast | Midlife Weight Gain Uncovered: What Diets Don’t Tell You!
The last mile is where patients quit. Or don't.
Bring the argument to your stage, your boardroom, or your build.